Currently Viewing:
Newsroom
Currently Reading
Lack of Payer Support a Barrier to Diabetes Prevention, CDC Reports
December 17, 2017 – Mary Caffrey
Pfizer Announces Phase 3 Trial for Atopic Dermatitis Treatment
December 15, 2017 – Samantha DiGrande
Average Profit Margin on Oncology Drugs For 340B Hospitals Nears 50%
December 15, 2017 – Jaime Rosenberg
Majority of Women With Breast Cancer Surgery Did Not Feel Fully Informed of Treatment Options
December 15, 2017 – Jaime Rosenberg
AJMC® in the Press, December 15, 2017
December 15, 2017 – AJMC Staff
What We're Reading: Medicare Lab Testing; CHIP Deadline; AMA Expands Diabetes Efforts
December 15, 2017 – AJMC Staff
5 Key Takeaways From ASH 2017
December 15, 2017 – Surabhi Dangi-Garimella, PhD
This Week in Managed Care: December 15, 2017
December 15, 2017
What We're Reading: Medical Device Tax; Marijuana and Vaping; Birth Control Without Prescriptions
December 14, 2017 – AJMC Staff

Study: Ultrasound Offers Early Clues Into Development of Inflammatory Arthritis

Kelly Davio
A new study suggests that ultrasound technology could allow for the earlier detection of inflammation, and therefore earlier treatment of inflammatory diseases, in patients with early joint pain.
Diagnosing inflammatory diseases such as rheumatoid arthritis early and initiating treatment with disease-modifying anti-rheumatic drugs is important in slowing disease progression and joint damage. However, it has been difficult for clinicians to identify which patients with joint pain will develop inflammatory arthritis (IA) prior to the clinical appearance of inflammation of the synovial membrane, or synovitis. A new study, published in Arthritis Research and Therapy, suggests that ultrasound technology could allow for the earlier detection of inflammation, and therefore earlier treatment of inflammatory diseases, in patients with early joint pain.

The multi-center prospective cohort study followed patients (n = 196) who had inflammatory joint complaints that could not be explained by other conditions, for a period of 1 year. Data collected at baseline and at 6-month and 12-month follow-ups included swollen joint count, tender joint count, diagnosis, medications, and laboratory values including rheumatoid factor and erythrocyte sedimentation rate.

At baseline, ultrasound examiners used a high-frequency linear array probe to evaluate 26 joints using both greyscale and power Doppler imaging, and found that 72 patients with joint pain (37%) had synovitis, as identified on the greyscale image, and 29 patients had a positive power Doppler signal. After 1 year of follow-up, 16% of patients with joint pain developed IA, and ultrasound had shown synovitis in 59% of those patients at the time of the baseline scan.

The researchers also found the following with respect to ultrasound’s predictive value:

  • The positive predictive value (PPV) for developing IA if 1 joint was identified as having synovitis using greyscale ultrasound was 26%, and the negative predictive value (NPV) was 74%
  • If a power Doppler signal was present for 1 joint, the PPV for a patients’ developing IA was 33%, and the NPV was 67%
  • When no joints were positive for synovia using ultrasound, NPV was 89%
The authors concluded that a positive power Doppler signal is associated with the development of IA after 1 year, and that ultrasounds can also help to identify which patients with joint pain will not develop IA. Further research is necessary, they write, to confirm their results regarding the diagnostic value of ultrasound to predict progression from early joint pain to an inflammatory disease.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!